Pricing Log in Create free account
Saturday 17 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

432.49 1.54 −0.35%
Market cap
$234.7B
P/E
26.7×
Fwd P/E
22.7×
Dividend yield
2.30%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Amgen Inc. (AMGN) Debt to equity

Alert me on Debt to equity

Amgen Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 4.9×, down 1.4× from fiscal 2025 (6.3×). Over the past ten years it has ranged from 1.1× (fiscal 2015) to 10.6× (fiscal 2022); the current reading is higher than 73% of that period. That is above the Drug Manufacturers General industry median of 0.6× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 6.3× (38.33%)
FY2024 10.2× (1.37%)
FY2023 10.4× (2.54%)
FY2022 10.6× 113.98%
FY2021 5.0× 41.81%
FY2020 3.5× 13.40%
FY2019 3.1× 13.89%
FY2018 2.7× 93.85%
FY2017 1.4× 20.92%
FY2016 1.2× 3.48%

Quarterly newest first

Period Debt to equity Change
Jun 2026 4.9× (21.40%)
Mar 2026 6.2× (1.10%)
Dec 2025 6.3× 11.13%
Sep 2025 5.7× (25.00%)
42 more quarters

Against its own ten years

Low 1.1× High 10.6×
Ten-year median 3.5×
Current reading's percentile 73

Debt to equity against peers

Company Debt to equity
ABBV AbbVie Inc. compare −12.0×
AZN AstraZeneca PLC compare 0.6×
NVO Novo Nordisk A/S compare 0.6×
PFE Pfizer Inc. compare 0.7×
NVS Novartis AG compare 1.1×
MRK Merck & Co., Inc. compare 1.2×
BMY Bristol Myers Squibb Company compare 1.9×
GILD Gilead Sciences, Inc. compare 2.2×
AMGN Amgen Inc. 4.9×
Drug Manufacturers General industry median 0.6×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on AMGN